Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Author: Justin Klein

Vensana in the News

Medtech investor duo seeks to ‘fill the gap’ in device sector private funding

Vensana in the News

New Minnesota-based fund has $225 million to invest in young med-tech companies

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
MedTech Strategist: Vensana Capital Closes Its Third Medtech Fund for $425 Million
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions